The expression of ribonuclear protein IMP3 in laryngeal carcinogenesis
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (6) , 152974
Abstract
No abstract availableKeywords
Funding Information
- project of University of Rijeka, Croatia (uniri-biomed-18-121)
This publication has 27 references indexed in Scilit:
- Expression of Insulin-Like Growth Factor II mRNA-Binding Protein 3 in Human Esophageal Adenocarcinoma and Its Precursor LesionsArchives of Pathology & Laboratory Medicine, 2011
- Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scoresBMC Cancer, 2010
- Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodesLaboratory Investigation, 2009
- Epidermal Growth Factor Receptor Protein Expression and Gene Amplification in Normal, Hyperplastic, and Cancerous Glottic Tissue: Immunohistochemical and Fluorescent in Situ Hybridization Study on Tissue MicroarraysCroatian Medical Journal, 2009
- Diffuse Expression of RNA-Binding Protein IMP3 Predicts High-Stage Lymph Node Metastasis and Poor Prognosis in Colorectal AdenocarcinomaAnnals of Surgical Oncology, 2009
- RNA‐binding protein insulin‐like growth factor II mRNA‐binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma†Hepatology, 2008
- IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the BladderClinical Cancer Research, 2008
- Current opinion in diagnosis and treatment of laryngeal carcinomaCancer Treatment Reviews, 2006
- Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinomaCancer, 2005
- Genetic mechanisms in squamous cell carcinoma of the head and neckOral Oncology, 2001